Literature DB >> 18001233

Larch arabinogalactan for dry eye protection and treatment of corneal lesions: investigations in rabbits.

Susi Burgalassi1, Nadia Nicosia, Daniela Monti, Giulia Falcone, Enrico Boldrini, Patrizia Chetoni.   

Abstract

PURPOSE: The aim of the present study was to investigate the corneal protective and healing properties of arabinogalactan (AG), a natural polysaccharide present in conifers of the genus Larix (Larch). AG was tested in comparison with other two polysaccharides possessing well-established properties in the treatment of dry eye: tamarind seed polysaccharide and hyaluronic acid.
METHODS: The AG formulation was subjected to the following investigations: rheologic measurements; evaluation of mucoadhesive properties by rheologic interaction with mucin; ferning test; and in vivo evaluation on rabbits, including treatment of an experimental dry eye; evaluation of the preocular retention; and evaluation of healing rate of experimental corneal wound.
RESULTS: AG dispersions showed a newtonian nonviscous behavior, eta = 1.6 mPa . s for 10% w/w solution; it possessed good mucoadhesive properties useful for retention on the eye surface. In fact, a prolonged time of residence in rabbit eyes was ascertained using fluorescein-labeled AG. Five percent (5.0%) w/w AG exerted a good protective effect against the appearance of corneal dry spots. It also reduced significantly the healing time of an experimental corneal lesion since 27 h after the first treatment.
CONCLUSIONS: These findings suggest that AG may be a potential therapeutic product for dry eye protection and for the treatment of corneal wounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18001233     DOI: 10.1089/jop.2007.0048

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

1.  A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone.

Authors:  Anna Maria Piras; Ylenia Zambito; Susi Burgalassi; Daniela Monti; Silvia Tampucci; Eleonora Terreni; Angela Fabiano; Federica Balzano; Gloria Uccello-Barretta; Patrizia Chetoni
Journal:  J Mater Sci Mater Med       Date:  2018-03-30       Impact factor: 3.896

2.  Arabinogalactan as active compound in the management of corneal wounds: in vitro toxicity and in vivo investigations on rabbits.

Authors:  Susi Burgalassi; Nadia Nicosia; Daniela Monti; Giulia Falcone; Enrico Boldrini; Ortenzio Fabiani; Carla Lenzi; Andrea Pirone; Patrizia Chetoni
Journal:  Curr Eye Res       Date:  2011-01       Impact factor: 2.424

Review 3.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

4.  Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment.

Authors:  Silvia Tampucci; Daniela Monti; Susi Burgalassi; Eleonora Terreni; Erica Zucchetti; Filippo Baldacci; Patrizia Chetoni
Journal:  Pharmaceutics       Date:  2018-08-25       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.